ArticleScientific reports2025
Monitoring of ultra-high performance concrete manufacturing for reproducible quality and waste reduction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultra-high performance concrete (UHPC) combines exceptional strength and durability, yet its industrial production is hampered by batch-to-batch variability that generates costly off-specification waste. Leveraging a 150-batch design-of-experiments dataset based on systematic variations of a single reference UHPC mix, this study takes a holistic view of the UHPC manufacturing chain and quantifies how fluctuations in raw material quality, storage conditions, dosing errors, mixer energy demand, and curing regimes affect the 28-day compressive strength. Ten diverse machine learning algorithms are benchmarked; the best-performing model explains ≥ 75 % of the strength variance with a prediction error ≤ 10 % under leave-one-out cross-validation. SHapley Additive exPlanations reveal that long-term curing temperature and humidity dominate strength development, followed by ingredient moisture and silica fume impurity. These insights are operationalized in an at-line, operator-in-the-loop recommendation system that explores the curing envelope and proposes end-of-mix, batch-specific adjustments before curing starts. In five validation cases, curing adjustments rescued 5/5 underperforming batches, eliminating 75 L of off-specification UHPC and-considering cement only with 600 kg/[Formula: see text] and 15 L per batch of UHPC made with white Portland cement-avoided ≈ 41 kg CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.